These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26695761)

  • 1. Adverse events in the treatment of MDR-TB patients within and outside the NTP in Pham Ngoc Thach hospital, Ho Chi Minh City, Vietnam.
    Hoa NB; Nhung NV; Khanh PH; Hai NV; Quyen BT
    BMC Res Notes; 2015 Dec; 8():809. PubMed ID: 26695761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Viet Nam.
    Hoa NB; Khanh PH; Chinh NV; Hennig CM
    Trop Med Int Health; 2014 Sep; 19(9):1076-81. PubMed ID: 24995611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam.
    Ngoc NB; Vu Dinh H; Thuy NT; Quang DV; Huyen CTT; Hoa NM; Anh NH; Dat PT; Hoa NB; Tiemersma E; Nhung NV
    PLoS One; 2021; 16(9):e0255357. PubMed ID: 34492031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study.
    Van LH; Phu PT; Vinh DN; Son VT; Hanh NT; Nhat LTH; Lan NH; Vinh TV; Trang NTM; Ha DTM; Thwaites GE; Thuong NTT
    BMC Infect Dis; 2020 Feb; 20(1):164. PubMed ID: 32087682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-drug resistant tuberculosis burden and risk factors: an update.
    Marahatta SB
    Kathmandu Univ Med J (KUMJ); 2010; 8(29):116-25. PubMed ID: 21209520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy.
    Gualano G; Mencarini P; Musso M; Mosti S; Santangelo L; Murachelli S; Cannas A; Di Caro A; Navarra A; Goletti D; Girardi E; Palmieri F
    PLoS One; 2019; 14(2):e0212948. PubMed ID: 30817779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
    Spies R; Hong HN; Trieu PP; Lan LK; Lan K; Hue NN; Huong NTL; Thao TTLN; Quang NL; Anh TDD; Vinh TV; Ha DTM; Dat PT; Hai NP; Van LH; Thwaites GE; Thuong NTT; Watson JA; Walker TM
    Emerg Infect Dis; 2024 Mar; 30(3):499-509. PubMed ID: 38407176
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Mai TQ; Martinez E; Menon R; Van Anh NT; Hien NT; Marais BJ; Sintchenko V
    Am J Trop Med Hyg; 2018 Dec; 99(6):1397-1406. PubMed ID: 30382014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [THE FREQUENCIES AND MANAGEMENT OF ADVERSE REACTIONS IN MULTI-DRUG RESISTANT TUBERCULOSIS TREATMENT].
    Sasaki Y; Yoshiyama T; Okumura M; Morimoto K; Miyamoto M; Irina ; Yoshimori K; Kurashima A; Ogata H; Gotoh H
    Kekkaku; 2017 Jan; 92(1):11-19. PubMed ID: 30646468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis.
    Tola HH; Holakouie-Naieni K; Lejisa T; Mansournia MA; Yaseri M; Tesfaye E; Mola M
    PLoS One; 2019; 14(6):e0218487. PubMed ID: 31211809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
    Pham TAM; Forse R; Codlin AJ; Phan THY; Nguyen TT; Nguyen N; Vo LNQ; Dat PT; Minh HDT; Nguyen LH; Nguyen HB; Nguyen NV; Bodfish M; Lönnroth K; Wingfield T; Annerstedt KS
    BMC Public Health; 2023 Dec; 23(1):2372. PubMed ID: 38042797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Events Associated with Treatment of Multidrug-Resistant Tuberculosis in China: An Ambispective Cohort Study.
    Zhang Y; Wu S; Xia Y; Wang N; Zhou L; Wang J; Fang R; Sun F; Chen M; Zhan S
    Med Sci Monit; 2017 May; 23():2348-2356. PubMed ID: 28520704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and factors associated with reported adverse-events among patients on multi-drug-resistant tuberculosis treatment in two referral hospitals in Uganda.
    Ategyeka PM; Muhoozi M; Naturinda R; Kageni P; Namugenyi C; Kasolo A; Kisaka S; Kiwanuka N
    BMC Infect Dis; 2023 Mar; 23(1):149. PubMed ID: 36899299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
    Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
    BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding how geographic, demographic and treatment history impact health outcomes of patients with multi-drug-resistant tuberculosis in Pakistan, 2014-2017.
    Iqbal F; Defer MK; Latif A; Hadi H
    Epidemiol Infect; 2020 Sep; 148():e253. PubMed ID: 32993828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance.
    Jaber AAS; Ibrahim B
    BMC Infect Dis; 2019 May; 19(1):464. PubMed ID: 31126246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
    Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
    BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam.
    Redwood L; Mitchell EMH; Viney K; Snow K; Nguyen TA; Dung LAT; Nguyen VN; Fox GJ
    Int J Tuberc Lung Dis; 2021 Jun; 25(6):461-467. PubMed ID: 34049608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.